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selayed Hyperenhancement
agnetic Resonance Imaging
or Sudden Cardiac Death
isk Stratification in
ypertrophic Cardiomyopathy
e have read with great interest the consensus guidelines intro-
uced by Goldberger et al. (1) concerning the evaluation of
oninvasive risk stratification techniques for identification of
atients at risk for sudden cardiac death (SCD). Concerning
ypertrophic cardiomyopathy (HCM), the authors conclusively
upport that the use of electrocardiography, signal-averaged elec-
rocardiography, treadmill exercise test, and 2-dimensional echo-
ardiography, along with obtaining a detailed personal and familial
istory, can successfully assess risk for SCD, even though no
andomized trials exist using these parameters (1).
SCD among HCM patients is mainly connected to the occur-
ence of ventricular tachycardia/ventricular fibrillation (VT/VF)
2). Many studies suggest that the extent of myocardial disarray-
brosis, predisposing to re-entry phenomena as part of a general
rrhythmogenic tendency, constitutes the main stimulus for
T/VF incidence (3,4). Delayed hyperenhancement magnetic
esonance imaging (MRI) accurately detects myocardial fibrosis
egree, and a statistically powerful correlation between fibrosis
xtent and incidence of VT/VF in HCM seems to have been
stablished by previous studies (5,6). However, the role of delayed
yperenhancement MRI as well as its diagnostic and prognostic
tility in assessment of SCD risk are not discussed in this
onsensus document. Obviously, more cohort studies are needed to
stablish an etiological relationship between scar size and the
ossibility of sudden death. Notwithstanding, delayed hyperen-
ancement MRI along with the aforementioned “screening” prac-
ices could offer a more precise estimation of risk for SCD in
CM patients.
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n Call at the
isconsin Heart Hospital
had just gotten home from rounds. While opening the Sunday
ewspaper, the phone rang. Dr. Clyde said, “Linda Bonobo was very
ethargic and wouldn’t get up for breakfast. Her breathing is labored
nd her edema is worse. We’re taking her to the hospital now.”
Linda is a 51-year-old insulin-dependent diabetic, mother of 12,
ho presented a month ago with edema, ascites, lethargy, anorexia,
nd shortness of breath. Echocardiography showed anteroapical
yskinesis of the left ventricle, and ejection fraction 35%. She was
reated with furosemide, lisinopril, metoprolol, and aspirin. Her
ppetite and level of physical activity improved. Her abdomen seemed
ess protuberant.
Linda has no prior history of heart disease. She has had insulin-
ependent diabetes for 5 years. Her urine has recently been negative
or glucose. Her low-density lipoprotein was 72 mg/dl, and her
igh-density lipoprotein was 142 mg/dl. No family history is avail-
ble: Linda was born in the wild in the jungles of the Democratic
epublic of Congo. Heart disease is a frequent cause of death in
onobos living in captivity. Being eaten by humans as “bush meat” is
ften the cause of death in wild bonobos. Bonobos are an endangered
pecies.
I parked in the Heart Hospital lot and walked across the street tohe Milwaukee Zoo. The Animal Health Center is just inside the
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December 29, 2009/January 5, 2010:77–81ate. As I arrived, a technician was warming up the ultrasound
achine just as Dr. Clyde and 3 assistants arrived by ambulance with
inda on a stretcher, anesthetized with ketamine. Bonobos are well
nown for their “human” characteristics, their communication skills
nd expressions of empathy, and their exuberant sexuality. They have
een conditioned to voluntarily submit to some medical procedures.
lthough bonobos are phylogenetically Homo sapiens’ closest rela-
ive, they are wild animals who will bite each other or their keepers.
hey must be placed under general anesthesia for extensive examina-
ions or treatment. General anesthesia is risky and unpleasant for the
onobos and is only used when essential.
A quick ultrasound examination showed markedly reduced left
entricular function with anteroapical thinning and dyskinesis, ascites,
nd large bilateral pleural effusions. Blood pressure was 90/60 mm
g. The electrocardiogram showed frequent premature ventricular
omplexes. Serum creatinine was 1.4 mg/dl. Serum potassium was
lightly elevated. Enzymes were consistent with passive hepatic
ongestion.
Linda’s overall condition seemed to improve slightly after thora-
entesis of 250-ml straw-colored fluid, but her cardiovascular and
espiratory function remained tenuous. Dr. Victoria Clyde, a zoo
eterinarian who has worked with the bonobos for many years,
onvened a “family” conference with the head primate curator and
everal zookeepers. Many of the treatments available to humans, such
s intensive nursing care, intravenous inotropic therapy or mechanical
irculatory assist, myocardial revascularization, and heart transplanta-
ion are simply not feasible for bonobos. Issues of prognosis, quality of
ife, and the compassion of those caring for Linda Bonobo were
imilar.
As Linda was unable to return to living independently in the
onobo quarters, and there were no other reasonable options, she was
uthanized. Post-mortem examination showed extensive coronary
therosclerosis and an extensive, old anteroapical myocardial
nfarction.
Linda Bonobo will be sorely missed by zoo staff and visitors, and
specially by the 21 remaining members of the bonobo colony,
here Linda served as a matriarch for 14 years.
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erfusion Cardiovascular
agnetic Resonance in the
linical Scenario of Patients
ith Coronary Artery Disease
n the recent paper by Patel et al. (1), the investigators stated that
ardiovascular magnetic resonance (CMR) and coronary multislice
omputed tomography angiography “do not currently provide
nformation on ischemic burden and are not assumed to be presentn the clinical scenarios;” in other words, they are not suitable to
ssess appropriateness of indications for coronary revascularization.
An increasing amount of literature supports the clinical appli-
ation of stress CMR (performed with adenosine/dipyridamole, or
ore frequently, dobutamine infusion) in patients with coronary
rtery disease (CAD) (2–4). Perfusion CMR has been validated
gainst positron emission tomography and quantitative coronary
ngiography in patients with ischemic heart disease (5,6). Schwit-
er et al. (5) demonstrated a sensitivity and specificity of 91% and
4% versus positron emission tomography and of 87% and 85%
ersus quantitative coronary angiography. A myocardial perfusion
eserve index derived by perfusion CMR images can distinguish
etween normal subjects and patients with CAD (7–10). Nandalur
t al. (11) recently conducted a meta-analysis of 37 studies on the
iagnostic efficacy of stress CMR in the detection of CAD and
oncluded that stress CMR, using either vasodilator or dobut-
mine, had high sensitivity and specificity for the diagnosis of
AD.
Possible advantages of perfusion CMR over myocardial perfu-
ion scintigraphy include higher resolution imaging that discrim-
nates between subendocardial and transmural perfusion defects,
nd no need for additional radiation burden in patients who are
ften in need of subsequent angioplasty (12). The MR-IMPACT
Magnetic Resonance Imaging for Myocardial Perfusion Assess-
ent in Coronary Artery Disease Trial) multicenter study recently
emonstrated that CMR perfusion has similar, if not superior,
iagnostic performance to myocardial perfusion scintigraphy in the
etection of CAD (13). Although myocardial perfusion scintigra-
hy is a robust technique with extensive prognostic data, there is
ow increasing evidence of the prognostic value of stress CMR in
atients with known or suspected CAD (14–18).
Both the American College of Cardiology Foundation/
merican Heart Association’s 2005 Clinical Competence State-
ent on Cardiac Imaging with Computed Tomography and
MR and the 2008 Training Statement on Multimodality Non-
nvasive Cardiovascular Imaging published in previous issues of the
ournal refer to perfusion CMR as a valid clinical diagnostic tool
or guidance of coronary revascularization therapy (19,20).
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